Trademarkia Logo

Canada

C$
BORA (STYLIZED)
SEARCHED

on 12 Jun 2024

Last Applicant/ Owned by

BORA PHARMACEUTICALS CO. LTD.

6F., NO.69, XING AI RDNEIHU DIST.TAIPEI CITY, 11494

TW

Serial Number

2059906 filed on 26th Oct 2020

Correspondent Address

FILLMORE RILEY LLP

1700 - 360 Main StreetWinnipeg

MANITOBA

CA

R3C3Z3

BORA (STYLIZED)

Trademark usage description

nutritional supplements for building body mass; nutritional supplements for general health and well-being; mineral nutritional supplements; antiallerg Read More

Classification Information


Class [005]
Nutritional supplements for building body mass; nutritional supplements for general health and well-being; mineral nutritional supplements; Antiallergic medicines; Sulphonamides in the nature of medicines; intestinal disorder medicine for the treatment of intestinal bacteria and parasites; intestinal disorder medicine for the treatment of ulcerative colitis; Medicines for dental purposes; Medicines for alleviating constipation; Motion sickness medicines; Medicines for the treatment of gastrointestinal diseases; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Medicinal preparations for the treatment of infectious diseases and for use in oncology; pharmaceutical preparations for use in ocular disorders; Antibacterial pharmaceuticals; Cardiovascular pharmaceutical preparations; Anti-diabetic pharmaceuticals; psychotropics; antihelmintics; anti-infectives; Pharmaceutical preparations for inducing erections; Injectable pharmaceuticals for treatment of anaphylactic reactions; Pharmaceuticals, namely, lipid lowering agents; Antimicrobial preparations for inhibiting microbiological decomposition; Pharmaceutical astringents; Pharmaceutical preparations for wounds; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Pharmaceutical skin lotions; antivirals; Pharmaceutical preparations for the treatment of hyperlipidemia; Pharmaceutical preparations for treating sunburn; Pharmaceutical preparations for skin care; antidepressants; Pharmaceutical preparations for use in urology; Pharmaceutical products and preparations for treating chloasma; Pharmaceutical preparations for treating diabetes; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical solutions used in dialysis; Pharmaceutical products for ophthalmological use; Anti-epileptic pharmaceutical preparations; Pharmaceutical preparations for treating allergies; Pharmaceutical preparations for treating hypertension; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for use in chemotherapy; anticoagulants; Pharmaceutical preparations for the treatment of hypercholesteremia; Pharmaceutical preparations for skin wounds; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating halitosis; Effervescent analgesic pharmaceutical preparations; Pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical preparations for treating asthma; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer; Analgesic and muscle relaxant pharmaceutical preparations; appetite suppressants; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical preparations for treating chemical imbalances; Pharmaceutical preparations for reducing sexual activity; pharmaceutical preparations for the treatment of infectious diseases, namely respiratory infections, eye infections; Pharmaceutical agents affecting digestive organs; Pharmaceutical agents affecting sensory organs; pharmaceutical preparations for the treatment of the diseases, disorders and infections of the central nervous system namely brain, movement, ocular motility and spinal cord diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical preparations, namely, injectable contraceptives; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products for the treatment of joint disease; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); Pharmaceutical preparations for the relief of insect bites; Pharmaceutical preparations for the treatment of bone fractures; pharmaceutical hormonal preparations, namely, corticosteroids, hormone replacement therapy preparations, oral contraceptives, thyroid hormone preparations; Pharmaceutical preparations for treating allergic rhinitis; Pharmaceutical preparations for the treatment of musculo-skeletal disorders; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for the treatment of the central nervous system, namely, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; Pharmaceutical agents for treating physically caused lesions; Pharmaceutical agents affecting peripheral nervous system; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for treating asthma; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood disorders, anxiety disorders, cognitive disorders, schizophrenia and bipolar disorders; pharmaceutical preparations for the prevention of osteoporosis; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical products and preparations against dry skin caused by pregnancy; pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; Pharmaceutical preparations, namely, an analgesic for human consumption taken orally; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical preparations, namely, a topical preparation for the treatment of ocular disorders prescribed by ophthalmologists, eye surgeons, and optometrists; Pharmaceutical preparations for treating and preventing tendon and muscle injuries and disorders, sports related injuries, and for knee cartilage regeneration; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Antibiotics; antifungal preparations; human vaccines; Pharmaceutical preparations and substances for the treatment of metabolic, endocrine, musculoskeletal, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, neurological, gastrointestinal; Pharmaceutical preparations for the prevention and treatment of disorders of the the cardio-vascular system, the respiratory system; for the treatment of inflammatory disorders; for use in hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders


Classification kind code

11

Class [040]
Custom manufacturing of medicines and nutritional supplements.


Classification kind code

11

Mark Details


Serial Number

2059906

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 22
on 12th Jun 2024
Search Recorded
Submitted for opposition 20
on 12th Jun 2024
Examiner's First Report
Submitted for opposition 287
on 11th May 2022
Pre-Assessment Letter Sent
Submitted for opposition 30
on 26th Oct 2020
Filed
Submitted for opposition 1
on 26th Oct 2020
Created
Submitted for opposition 31
on 26th Oct 2020
Formalized